Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent
In Brief: GAO Says Congress Should Re-Examine Delaney Clause, Consider Making It More Flexible
CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments
Aging Institute Encourages Cancer Investigators To Include Elderly
BRMP Investigators Find New Lung Tumor Antigen, Seek Developers
Summit Conference Reviews Leads In Leukemia, Lymphoma
Cell Behavior Changes Noted At Baltimore Symposium
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40% - California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Facing stage 4 cholangiocarcinoma, Keaton Herzer moved mountains to take off-label therapy, get a transplant
Two years later, he has no evidence of disease - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
